CYP2C19 and transient ischemic attack: In fact, apart from CYP2C19 polymorphisms, many other genetic polymorphisms that are relevant to the disposition and efficacy of clopidogrel may influence the pharmacodynamic effects of clopidogrel for patients with an ischemic stroke or a TIA.